Antibiotics. Simplified. Jason C. Gallagher PharmD, BCPS. Conan MacDougall PharmD, MAS, BCPS. Clinical Associate Professor Temple University
|
|
- Adele Daniel
- 5 years ago
- Views:
Transcription
1 Antibiotics Simplified third EDITION Jason C. Gallagher PharmD, BCPS Conan MacDougall PharmD, MAS, BCPS Clinical Associate Professor Temple University Associate Professor of Clinical Pharmacy School of Pharmacy University of California San Francisco San Francisco, CA Adjunct Assistant Professor of Pharmacology and Physiology School of Medicine Drexel University Philadelphia, PA
2 World Headquarters Jones & Bartlett Learning 5 Wall Street Burlington, MA info@jblearning.com Jones & Bartlett Learning books and products are available through most bookstores and online booksellers. To contact Jones & Bartlett Learning directly, call , fax , or visit our website, Substantial discounts on bulk quantities of Jones & Bartlett Learning publications are available to corporations, professional associations, and other qualified organizations. For details and specific discount information, contact the special sales department at Jones & Bartlett Learning via the above contact information or send an to specialsales@jblearning.com. Copyright 2014 by Jones & Bartlett Learning, LLC, an Ascend Learning Company All rights reserved. No part of the material protected by this copyright may be reproduced or utilized in any form, electronic or mechanical, including photocopying, recording, or by any information storage and retrieval system, without written permission from the copyright owner. The content, statements, views, and opinions herein are the sole expression of the respective authors and not that of Jones & Bartlett Learning, LLC. Reference herein to any specific commercial product, process, or service by trade name, trademark, manufacturer, or otherwise does not constitute or imply its endorsement or recommendation by Jones & Bartlett Learning, LLC and such reference shall not be used for advertising or product endorsement purposes. All trademarks displayed are the trademarks of the parties noted herein. Antibiotics Simplified, Third Edition is an independent publication and has not been authorized, sponsored, or otherwise approved by the owners of the trademarks or service marks referenced in this product. There may be images in this book that feature models; these models do not necessarily endorse, represent, or participate in the activities represented in the images. Any screenshots in this product are for educational and instructive purposes only. Any individuals and scenarios featured in the case studies throughout this product may be real or fictitious, but are used for instructional purposes only. The authors, editor, and publisher have made every effort to provide accurate information. However, they are not responsible for errors, omissions, or for any outcomes related to the use of the contents of this book and take no responsibility for the use of the products and procedures described. Treatments and side effects described in this book may not be applicable to all people; likewise, some people may require a dose or experience a side effect that is not described herein. Drugs and medical devices are discussed that may have limited availability controlled by the Food and Drug Administration (FDA) for use only in a research study or clinical trial. Research, clinical practice, and government regulations often change the accepted standard in this field. When consideration is being given to use of any drug in the clinical setting, the healthcare provider or reader is responsible for determining FDA status of the drug, reading the package insert, and reviewing prescribing information for the most up-to-date recommendations on dose, precautions, and contraindications, and determining the appropriate usage for the product. This is especially important in the case of drugs that are new or seldom used. Production Credits Publisher: William Brottmiller Senior Acquisitions Editor: Katey Birtcher Editorial Assistant: Sean Fabery Production Editor: Jill Morton Marketing Manager: Grace Richards VP, Manufacturing and Inventory Control: Therese Connell Composition: Lapiz, Inc. Cover Design: Michael O Donnell Cover Image: (pills) Photos.com, (bacteria) Courtesy of Rocky Mountain Laboratories, NIAID, NIH Printing and Binding: Edwards Brothers Malloy Cover Printing: Edwards Brothers Malloy Library of Congress Cataloging-in-Publication Data 6048 Printed in the United States of America
3 Contents Acknowledgments Introduction New to the Third Edition vii ix xiii Part 1: Considerations with Antibiotic Therapy 1 Chapter 1: The Wonderful World of Microbiology 3 Chapter 2: General Approach to Infectious Diseases 15 Chapter 3: Antibiotic Pharmacokinetics 23 Chapter 4: Antibiotic Pharmacodynamics 33 Chapter 5: Adverse Consequences of Antibiotic Use 41 Part 2: Antibacterial Drugs 47 Chapter 6: Beta-Lactams 49 Penicillins 51 Natural Penicillins 53 Antistaphylococcal Penicillins 57 Aminopenicillins 59 Antipseudomonal Penicillins 63 Beta-Lactamase Inhibitor Combinations 65 Cephalosporins 69 First-Generation Cephalosporins 71 Second-Generation Cephalosporins 73 iii
4 iv Contents Third-Generation Cephalosporins 77 Fourth-Generation Cephalosporins 81 Fifth-Generation Cephalosporins 83 Carbapenems 87 Monobactams 91 Chapter 7: Glycopeptides 93 Chapter 8: Fluoroquinolones 97 Chapter 9: Aminoglycosides 101 Chapter 10: Tetracyclines and Glycylcyclines 105 Chapter 11: Macrolides and Ketolides 109 Chapter 12: Oxazolidinones 113 Chapter 13: Nitroimidazoles 117 Chapter 14: Nitrofurans and Fosfomycin 121 Chapter 15: Streptogramins 125 Chapter 16: Cyclic Lipopeptides 129 Chapter 17: Folate Antagonists 133 Chapter 18: Lincosamides 137 Chapter 19: Polymyxins 141 Chapter 20: Fidaxomicin 145 PART 3: Antimycobacterial Drugs 147 Chapter 21: Antimycobacterial Drugs 149 Chapter 22: Rifamycins 153 Chapter 23: Isoniazid 157 Chapter 24: Pyrazinamide 161 Chapter 25: Ethambutol 163 PART 4: Antifungal Drugs 165 Chapter 26: Antifungal Drugs 167 Chapter 27: Polyenes 171
5 Contents v Chapter 28: Antifungal Antimetabolites 175 Chapter 29: Azoles 179 Fluconazole 181 Itraconazole 185 Voriconazole 189 Posaconazole 193 Chapter 30: Echinocandins 197 PART 5: Antiviral Drugs 201 Chapter 31: Antiviral Drugs 203 Chapter 32: Anti-Herpes Simplex Virus and Varicella-Zoster Virus Agents 207 Chapter 33: Anti-Cytomegalovirus Agents 211 Chapter 34: Neuraminidase Inhibitors 215 Chapter 35: Antiretroviral Drugs 219 Nucleoside and Nucleotide Reverse Transcriptase Inhibitors 221 Non-nucleoside Reverse Transcriptase Inhibitors (NNRTIs) 225 Protease Inhibitors 229 Integrase Inhibitors 235 Entry and Fusion Inhibitors 239 Chapter 36: Antiviral Interferons 241 Chapter 37: Serine Protease Inhibitors 245 Chapter 38: Ribavirin 249 Chapter 39: Hepatitis B Nucleoside Analogs 253 PART 6: Antiparasitic Drugs 255 Chapter 40: Antiparasitic Drugs 257 Chapter 41: Quinolines 261 Chapter 42: Atovaquone 265
6 vi Contents Chapter 43: Benzimidazoles 269 Chapter 44: Pentamidine 273 Chapter 45: Ivermectin 277 Appendix 1: Selected Normal Human Flora 280 Appendix 2: Spectrum of Activity 282 Appendix 3: Empiric Regimens for Common Infections 288 Index 293
7 Acknowledgments Our thanks go to those who helped edit all three editions of Antibiotics Simplified, and to our wives, who put up with us and took care of our kids while we wrote the Third Edition. We dedicate this text to the pharmacy students of Temple University and University of California San Francisco. We hope you find it useful. vii
8
9 Introduction Antibiotics the word sends terror coursing through the veins of students and makes many healthcare professionals uncomfortable. The category of antibiotics actually contains many different classes of drugs that differ in spectrum of activity, adverse effect profiles, pharmacokinetics and pharmacodynamics, and clinical utility. These classes can seem bewildering and beyond comprehension. We believe that taking a logical, stepwise approach to learning the pharmacotherapy of infectious diseases can help burn away the mental fog preventing optimal use and understanding of these drugs. Learning the characteristics of antibiotics greatly simplifies learning infectious disease pharmacotherapy. Students and clinicians who attempt to learn the antibiotics of choice for different types of infections before knowing the characteristics of those drugs never truly understand the context of what they are attempting to learn. Once the characteristics of the antibiotics are known, making a logical choice to treat an infection is much easier. This approach takes some time up front, but it will be well worth the effort when one realizes that the pharmacotherapy of all infections is fundamentally similar and logical. ix
10 x Introduction How to Use This Book We wrote this book in an effort to condense the many facts that are taught about antibiotics in pharmacology and pharmacotherapy courses into one quick reference guide. It is meant to supplement material learned in pharmacology, not to supplant it. Use this book as a reference when you encounter a class of antibiotics that you know you have heard about; it will remind you of key points you may have forgotten. This book contains six parts. Part 1 reviews basic microbiology and how to approach the pharmacotherapy of a patient with a presumed infection. The chapters in Parts 2 6 provide concise reviews of various classes of antibacterial, antimycobacterial, antifungal, antiviral, and antiparasitic drugs. Again, this book is intended to supplement your other pharmacology textbooks. These chapters give key points about each class of antibiotics they are not thorough reviews. The appendices contain references that may help in daily use. Format of the Drug Class Reviews Each drug class chapter follows the same basic format. The agents belonging to each class are listed first. The drugs used most commonly in practice are bolded. Mechanism of Action This section concisely summarizes the mechanism of action of the antibiotic class. Spectrum This section summarizes key organisms against which each class has or lacks activity. The spectra listed are not exhaustive.
11 Introduction xi Adverse Effects This section lists key adverse effects. This list is not exhaustive, but it gives the most common and/or concerning adverse effects of each class. Dosing Issues This section discusses common problems or potential errors in drug dosing for select drug classes. Important Facts This section provides a summary of significant facts for and aspects of each drug class. What They re Good For This section lists some of the most common and/or useful indications for the agents in the class. Often the agents discussed have not been approved for these indications by the U.S. Food and Drug Administration (FDA), but they are commonly used for them anyway. Conversely, many FDA indications that the antibiotics do have are not listed here, because they are often out-of-date. Don t Forget! In this section, we list points that are often overlooked or especially important when dealing with the drug class. As you read this book, try to think of situations in which the antibiotics would be useful to your patients. Think of why an antibiotic is useful for an indication; don t just learn that it is. It is our sincere hope that you too have that magic moment where the world of antibiotics and the study of infectious diseases click together. Let us know when it happens.
12
13 New to the Third Edition The Third Edition of Antibiotics Simplified expands on the drug classes covered in the first while retaining the key point focus of the text that has made it successful. The Third Edition includes expanded coverage of antiviral agents, particularly new-andold treatments for hepatitis B and C infections. New antibiotics have been added since the Second Edition, and the chapters for each class were updated with new clinical and scientific findings. xiii
ESSENTIALS OF ANTIMICROBIAL PHARMACOLOGY
ESSENTIALS OF ANTIMICROBIAL PHARMACOLOGY Essentials of Antimicrobial Pharmacology A Guide to Fundamentals for Practice PAUL H. AXELSEN, MD University of Pennsylvania School of Medicine Philadelphia, PA
More informationAntimicrobial Drugs. PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R
PowerPoint Lecture Presentations prepared by Bradley W. Christian, McLennan Community College C H A P T E R 20 Antimicrobial Drugs The History of Chemotherapy Selective toxicity: selectively finding and
More informationChallenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems
Micro 301 Antimicrobial Drugs 11/7/12 Significance of antimicrobial drugs Challenges Emerging resistance Fewer new drugs MRSA and other resistant pathogens are major problems Definitions Antibiotic Selective
More informationWHO perspective on antimicrobial resistance
WHO perspective on antimicrobial resistance Bernadette Abela-Ridder, DVM, MSc, PhD Global Foodborne Infections Network (GFN) Coordinator Department of Food Safety and Zoonoses (FOS) 1 Overview of presentation
More informationANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS
ANTIBIOTICS: TECHNOLOGIES AND GLOBAL MARKETS PHM025D March 2016 Neha Maliwal Project Analyst ISBN: 1-62296-252-4 BCC Research 49 Walnut Park, Building 2 Wellesley, MA 02481 USA 866-285-7215 (toll-free
More informationTable 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities.
Table 1. Commonly encountered or important organisms and their usual antimicrobial susceptibilities. Gram-positive cocci: Staphylococcus aureus: *Resistance to penicillin is almost universal. Resistance
More informationClinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: HIM*, Medicaid
Clinical Policy: (Zyvox) Reference Number: CP.PMN.27 Effective Date: 09.01.06 Last Review Date: 02.19 Line of Business: HIM*, Medicaid Coding Implications Revision Log See Important Reminder at the end
More informationbacteria fungi HOW? WHAT? protozoa virus Controlling Microbial Growth in the Body: Antimicrobial Drugs
PowerPoint Lecture Presentations prepared by Mindy Miller-Kittrell, North Carolina State University C H A P T E R 10 Controlling Microbial Growth in the Body: Antimicrobial Drugs bacteria fungi HOW? WHAT?
More informationControlling Microbial Growth in the Body: Antimicrobial Drugs
PowerPoint Lecture Presentations prepared by Mindy Miller-Kittrell, North Carolina State University C H A P T E R 10 Controlling Microbial Growth in the Body: Antimicrobial Drugs bacteria fungi HOW? WHAT?
More informationControlling Microbial Growth in the Body: Antimicrobial Drugs
PowerPoint Lecture Presentations prepared by Mindy Miller-Kittrell, North Carolina State University C H A P T E R 10 Controlling Microbial Growth in the Body: Antimicrobial Drugs Interesting News https://www.technologyreview.com/s/601138/the-fridge-laserthat-detects-bacteria-crawling-all-over-food/
More informationAntimicrobial agents. are chemicals active against microorganisms
Antimicrobial agents are chemicals active against microorganisms Antibacterial Agents Are chemicals active against bacteria Antimicrobials Antibacterial Antifungal Antiviral Antiparasitic: -anti protozoan
More information1 January 2017, It is Coming Preparation for VFD Changes Beginning 1 January 2017
1 January 2017, It is Coming Preparation for VFD Changes Beginning 1 January 2017 ASM-00007 1 CHAPTERS Background: Food and Drug Administration (FDA) guidance documents Introduction: Veterinary Feed Directive
More informationControlling Microbial Growth in the Body: Antimicrobial Drugs
PowerPoint Lecture Presentations prepared by Mindy Miller-Kittrell, North Carolina State University C H A P T E R 10 Controlling Microbial Growth in the Body: Antimicrobial Drugs bacteria fungi HOW? WHAT?
More informationHealthcare Facilities and Healthcare Professionals. Public
Document Title: DOH Guidelines for Antimicrobial Stewardship Programs Document Ref. Number: DOH/ASP/GL/1.0 Version: 1.0 Approval Date: 13/12/2017 Effective Date: 14/12/2017 Document Owner: Applies to:
More informationClinical Policy: Linezolid (Zyvox) Reference Number: CP.PMN.27 Effective Date: Last Review Date: Line of Business: Oregon Health Plan
Clinical Policy: (Zyvox) Reference Number: CP.PMN.27 Effective Date: 07.01.18 Last Review Date: 05.18 Line of Business: Oregon Health Plan Revision Log See Important Reminder at the end of this policy
More informationWHO efforts to reduce the impact on public and animal health of antibiotic use in animals. Dr Danilo Lo Fo Wong Senior Adviser AMR
WHO efforts to reduce the impact on public and animal health of antibiotic use in animals Dr Danilo Lo Fo Wong Senior Adviser AMR Antimicrobial resistance (AMR): a public and animal health issue Widespread
More informationThe pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens
The pharmacological and microbiological basis of PK/PD : why did we need to invent PK/PD in the first place? Paul M. Tulkens Cellular and Molecular Pharmacology Unit Catholic University of Louvain, Brussels,
More informationAntimicrobial consumption
Antimicrobial consumption Annual Epidemiological Report for 2017 Key facts Twenty-seven countries, comprising 25 EU Member States and two EEA countries (Iceland and Norway) reported data on antimicrobial
More informationMike Apley Kansas State University
Mike Apley Kansas State University 2003 - Daptomycin cyclic lipopeptides 2000 - Linezolid - oxazolidinones 1985 Imipenem - carbapenems 1978 - Norfloxacin - fluoroquinolones 1970 Cephalexin - cephalosporins
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: (Nuzyra) Reference Number: CP.PMN.## Effective Date: 11.20.18 Last Review Date: 02.19 Line of Business: Commercial, TBD HIM*, Medicaid Coding Implications Revision Log See Important Reminder
More informationCSLO3. Distinguish between mechanisms of physical and chemical agents to control microbial populations.
PowerPoint Lecture Presentations prepared by Mindy Miller-Kittrell, North Carolina State University CSLO3. Distinguish between mechanisms of physical and chemical agents to control microbial populations.
More informationChapter 20. Antimicrobial Drugs. Lectures prepared by Christine L. Case Pearson Education, Inc. Lectures prepared by Christine L.
Chapter 20 Antimicrobial Drugs Lectures prepared by Christine L. Case Copyright Lectures prepared by Christine L. Case The History of Chemotherapy Learning Objectives 20-1 Identify the contributions of
More informationOverview of antibiotic combination issues.
Overview of antibiotic combination issues. Professor Anthony Coates St George s, University of London Founder, CSO, Helperby Therapeutics Ltd The most serious problem is Carbapenem resistant Gram-negatives
More informationThe Future of Antibiotic Alternatives
The Future of Antibiotic Alternatives @Elanco #feedthe9 Grady Bishop Sr. Director Market Access Elanco 1 The Global Landscape our WHY 2 Today s 3 Food Security Realities 3 The Protein Gap 4 The impact
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.HNMC.04 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important
More informationAntimicrobial Stewardship Strategy: Dose optimization
Antimicrobial Stewardship Strategy: Dose optimization Review and individualization of antimicrobial dosing based on the characteristics of the patient, drug, and infection. Description This is an overview
More informationAntimicrobial Stewardship in the Hospital Setting
GUIDE TO INFECTION CONTROL IN THE HOSPITAL CHAPTER 12 Antimicrobial Stewardship in the Hospital Setting Authors Dan Markley, DO, MPH, Amy L. Pakyz, PharmD, PhD, Michael Stevens, MD, MPH Chapter Editor
More informationDuke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients
Duke University Hospital Guideline for Empiric Inpatient Treatment of Cancer- Related Neutropenic Fever in Adult Patients PURPOSE Fever among neutropenic patients is common and a significant cause of morbidity
More informationPrinciples of Antimicrobial therapy
Principles of Antimicrobial therapy Laith Mohammed Abbas Al-Huseini M.B.Ch.B., M.Sc, M.Res, Ph.D Department of Pharmacology and Therapeutics Antimicrobial agents are chemical substances that can kill or
More informationAntimicrobial Use and Resistance (AUR) Module
Antimicrobial Use and Resistance () Module Table of Contents Introduction 1 1. Antimicrobial Use (AU) Option 2 Introduction 2 Requirements 3 Data Analyses 7 Appendix A. Table of Instructions: Antimicrobial
More informationAntimicrobial Stewardship Program
Antimicrobial Stewardship Program David R. Woodard, MSc, FSHEA, CIC CDC: Antibiotic Resistance Threats in the United States, 2013 http://www.cdc.gov/drugresistance/threat-report-2013/pdf/ CDC Threat Levels
More informationAntimicrobial Stewardship Strategy: Antibiograms
Antimicrobial Stewardship Strategy: Antibiograms A summary of the cumulative susceptibility of bacterial isolates to formulary antibiotics in a given institution or region. Its main functions are to guide
More informationClinical Policy: Clindamycin (Cleocin) Reference Number: CP.HNMC.08 Effective Date: Last Review Date: Line of Business: Medicaid - HNMC
Clinical Policy: (Cleocin) Reference Number: CP.HNMC.08 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy
More information5 Killer Dog Training Mindmaps to Help You Effectively Train Your Dog in 30 Days
5 Killer Dog Training Mindmaps to Help You Effectively Train Your Dog in 30 Days Author: Rachel MacAdams Dog Lovers Post Dot Com #1 Online Dog Magazine Source Disclaimer & Legal Notice While all attempts
More informationAntimicrobial Stewardship Program: Local Experience
Antimicrobial Stewardship Program: Local Experience Dr. WU Tak Chiu Associate Consultant Division of Infectious Diseases Department of Medicine Queen Elizabeth Hospital 18th January 2011 QUEEN ELIZABETH
More informationBarriers to Intravenous Penicillin Use for Treatment of Nonmeningitis
JCM Accepts, published online ahead of print on 7 July 2010 J. Clin. Microbiol. doi:10.1128/jcm.01012-10 Copyright 2010, American Society for Microbiology and/or the Listed Authors/Institutions. All Rights
More informationSelective toxicity. Antimicrobial Drugs. Alexander Fleming 10/17/2016
Selective toxicity Antimicrobial Drugs Chapter 20 BIO 220 Drugs must work inside the host and harm the infective pathogens, but not the host Antibiotics are compounds produced by fungi or bacteria that
More informationChemotherapy of bacterial infections. Part II. Mechanisms of Resistance. evolution of antimicrobial resistance
Chemotherapy of bacterial infections. Part II. Mechanisms of Resistance evolution of antimicrobial resistance Mechanism of bacterial genetic variability Point mutations may occur in a nucleotide base pair,
More informationAntimicrobial Stewardship 101
Antimicrobial Stewardship 101 Betty P. Lee, Pharm.D. Pediatric Infectious Disease/Antimicrobial Stewardship Pharmacist Lucile Packard Children s Hospital Stanford Disclosure I have no actual or potential
More informationCONSUMPTION OF ANTIBIOTICS IN PUBLIC ACUTE HOSPITALS IN IRELAND DATA TO END OF 2012
CONSUMPTION OF ANTIBIOTICS IN PUBLIC ACUTE HOSPITALS IN IRELAND DATA TO END OF 12 MAIN POINTS There was a 5% rise in the median usage rate from 83.1 Defined Daily Doses per Bed Days Used (DDD/BDU) for
More informationFoundation in Pharmacology - 2 (Year 3 Semester 1)
Foundation in - 2 (Year 3 Semester 1) Credits: 0.5 Foundation in - 2 (Credits: 2.0 Foundation in 1) Duration: 3 weeks (15 days) Topic & Concepts Objectives Time Dept. T/L activity Comments At the end of
More informationAntibacterial therapy 1. د. حامد الزعبي Dr Hamed Al-Zoubi
Antibacterial therapy 1 د. حامد الزعبي Dr Hamed Al-Zoubi ILOs Principles and terms Different categories of antibiotics Spectrum of activity and mechanism of action Resistancs Antibacterial therapy What
More informationSummary of the latest data on antibiotic consumption in the European Union
Summary of the latest data on antibiotic consumption in the European Union ESAC-Net surveillance data November 2016 Provision of reliable and comparable national antimicrobial consumption data is a prerequisite
More informationConsiderations in antimicrobial prescribing Perspective: drug resistance
Considerations in antimicrobial prescribing Perspective: drug resistance Hasan MM When one compares the challenges clinicians faced a decade ago in prescribing antimicrobial agents with those of today,
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority
Quality ID #407: Appropriate Treatment of Methicillin-Susceptible Staphylococcus Aureus (MSSA) Bacteremia National Quality Strategy Domain: Effective Clinical Care Meaningful Measure Area: Healthcare Associated
More informationWhat To Expect When Your Cat Has Cancer:
What To Expect When Your Cat Has Cancer: A Survival Handbook For Feline Cancer & Treatment ALLYSON GOLDING What To Expect When Your Cat Has Cancer: A Survival Handbook For Feline Cancer & Treatment ALLYSON
More informationAntibiotics. Antimicrobial Drugs. Alexander Fleming 10/18/2017
Antibiotics Antimicrobial Drugs Chapter 20 BIO 220 Antibiotics are compounds produced by fungi or bacteria that inhibit or kill competing microbial species Antimicrobial drugs must display selective toxicity,
More informationBurton's Microbiology for the Health Sciences. Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents
Burton's Microbiology for the Health Sciences Chapter 9. Controlling Microbial Growth in Vivo Using Antimicrobial Agents Chapter 9 Outline Introduction Characteristics of an Ideal Antimicrobial Agent How
More information2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY. MEASURE TYPE: Process
Quality ID #407: Appropriate Treatment of Methicillin-Susceptible Staphylococcus Aureus (MSSA) Bacteremia National Quality Strategy Domain: Effective Clinical Care 2018 OPTIONS FOR INDIVIDUAL MEASURES:
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Doxycycline Hyclate (Acticlate, Doryx), Doxycline (Oracea), Minocycline (Solodyn, Ximino) Reference Number: CP.CPA.120 Effective Date: 11.16.16 Last Review Date: 11.17 Line of Business:
More informationChildrens Hospital Antibiogram for 2012 (Based on data from 2011)
Childrens Hospital Antibiogram for 2012 (Based on data from 2011) Prepared by: Department of Clinical Microbiology, Health Sciences Centre For further information contact: Andrew Walkty, MD, FRCPC Medical
More informationIntroduction to Antimicrobial Therapy
Introduction to Antimicrobial Therapy Christine Kubin, Pharm.D., BCPS Clinical Pharmacist, Infectious Diseases Case #2 68 y.o. female with HTN, anxiety with chest pain symptoms 7/27/05: Cath - 3 vessel
More informationSee Important Reminder at the end of this policy for important regulatory and legal information.
Clinical Policy: Reference Number: CP.HNMC.24 Effective Date: 07.01.17 Last Review Date: 02.18 Line of Business: Medicaid - HNMC Revision Log See Important Reminder at the end of this policy for important
More informationIntroduction to Antimicrobial Therapy
Case #1 Introduction to Antimicrobial Therapy Christine Kubin, Pharm.D., BCPS Clinical Pharmacist, Infectious Diseases L.G. is a 78 yo woman admitted for cardiac cath. 3-vessel disease was identified and
More informationOther Beta - lactam Antibiotics
Other Beta - lactam Antibiotics Assistant Professor Dr. Naza M. Ali Lec 5 8 Nov 2017 Lecture outlines Other beta lactam antibiotics Other inhibitors of cell wall synthesis Other beta-lactam Antibiotics
More informationSales survey of Veterinary Medicinal Products containing Antimicrobials in France Volumes and estimated exposure of animals to antimicrobials
Sales survey of Veterinary Medicinal Products containing Antimicrobials in France - 2013 Volumes and estimated exposure of animals to antimicrobials October 2014 Scientific Edition Sales survey of Veterinary
More informationIntroduction to Antimicrobials. Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail.
Introduction to Antimicrobials Rachel J. Gordon, MD, MPH Lecture Aim: To provide a brief introduction to antibiotics. Future lectures will go into more detail. Major Learning Objectives: 1) Learn the different
More informationSaunders Handbook Of Veterinary Drugs: Small And Large Animal, 3e (Handbook Of Veterinary Drugs (Saunders)) PDF
Saunders Handbook Of Veterinary Drugs: Small And Large Animal, 3e (Handbook Of Veterinary Drugs (Saunders)) PDF Concise and easy-to-use, Saunders Handbook of Veterinary Drugs, 3rd Edition helps you find
More informationPrinciples of Anti-Microbial Therapy Assistant Professor Naza M. Ali. Lec 1
Principles of Anti-Microbial Therapy Assistant Professor Naza M. Ali Lec 1 28 Oct 2018 References Lippincott s IIIustrated Reviews / Pharmacology 6 th Edition Katzung and Trevor s Pharmacology / Examination
More informationAntibiotics A Multidisciplinary Approach
Antibiotics A Multidisciplinary Approach Antibiolies A Multidisciplinary Approach Giancarlo Lancini Marion Merrell Dow Research Institute (MMDRI) Lepetit Research Center Gerenzano (Varese), Italy Francesco
More informationAntimicrobial Stewardship Strategy: Formulary restriction
Antimicrobial Stewardship Strategy: Formulary restriction Restricted dispensing of targeted antimicrobials on the hospital s formulary, according to approved criteria. The use of restricted antimicrobials
More informationGeneral Infectious Disease Concepts/Resources
General Infectious Disease Concepts/Resources Learning Objectives: 1. Distinguish between foundational infectious disease concepts including gram positive and negative bacteria, bacteriostatic and bactericidal
More informationFor analyst certification and disclosures please see page 7
Physician Survey Survey of Healthcare Professionals on Community-Acquired Bacterial Pneumonia We conducted a survey on prescribing habits for community-acquired bacterial pneumonia (CABP) in order to better
More informationNorthwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16
Northwestern Medicine Central DuPage Hospital Antimicrobial Criteria Updated 11/16/16 These criteria are based on national and local susceptibility data as well as Infectious Disease Society of America
More informationTREAT Steward. Antimicrobial Stewardship software with personalized decision support
TREAT Steward TM Antimicrobial Stewardship software with personalized decision support ANTIMICROBIAL STEWARDSHIP - Interdisciplinary actions to improve patient care Quality Assurance The aim of antimicrobial
More informationNational Clinical Guideline Centre Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults
National Clinical Guideline Centre Antibiotic classifications Pneumonia Diagnosis and management of community- and hospital-acquired pneumonia in adults Clinical guideline 191 Appendix N 3 December 2014
More informationOptimizing Antimicrobial Stewardship Activities Based on Institutional Resources
Optimizing Antimicrobial Stewardship Activities Based on Institutional Resources Andrew Hunter, PharmD, BCPS Infectious Diseases Clinical Pharmacy Specialist Michael E. DeBakey VA Medical Center Andrew.hunter@va.gov
More informationAntibacterial Resistance: Research Efforts. Henry F. Chambers, MD Professor of Medicine University of California San Francisco
Antibacterial Resistance: Research Efforts Henry F. Chambers, MD Professor of Medicine University of California San Francisco Resistance Resistance Dose-Response Curve Antibiotic Exposure Anti-Resistance
More informationChapter 51. Clinical Use of Antimicrobial Agents
Chapter 51 Clinical Use of Antimicrobial Agents History of antimicrobial therapy Early 17 th century Cinchona bark was used as an important historical remedy against malaria. 1909 Paul Ehrlich sought a
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority
Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate Use of Healthcare 2019 COLLECTION
More informationGeneral Approach to Infectious Diseases
General Approach to Infectious Diseases 2 The pharmacotherapy of infectious diseases is unique. To treat most diseases with drugs, we give drugs that have some desired pharmacologic action at some receptor
More informationCME/CE QUIZ CME/CE QUESTIONS. a) 20% b) 22% c) 34% d) 35% b) Susceptible and resistant strains of typical respiratory
CME/CE QUIZ CME/CE QUESTIONS Continuing Medical Education Accreditation This activity has been planned and implemented in accordance with the Essential Areas and Policies of the Accreditation Council for
More informationV E T E R I N A R Y C O U N C I L O F I R E L A N D ETHICAL VETERINARY PRACTICE
V E T E R I N A R Y C O U N C I L O F I R E L A N D ETHICAL VETERINARY PRACTICE ETHICAL VETERINARY PRACTICE The term Ethical Veterinary Practice is a wide ranging one, implying as it does, compliance with
More informationICAAC. Key words: antibacterial agent development approval. linezolid β. chloramphenicol tetracycline colistin mupirocin teicoplanin
16 11 1 16 11 25 58 238 154 β 65 25 24 20 10 46 10 19 5 10 10 10 ICAAC Key words: antibacterial agent development approval 1946 60 238 10 Fig. 1 β 95 40 1976 1995 20 60 β β 40 chloramphenicol tetracycline
More information3/23/2017. Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc. Kathryn G. Smith: Nothing to disclose
Kathryn G. Smith, PharmD PGY1 Pharmacy Resident Via Christi Hospitals Wichita, Inc Kathryn G. Smith: Nothing to disclose Describe the new updates and rationale for them Relay safety concerns with use of
More informationQuality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction
Quality ID #66: Appropriate Testing for Children with Pharyngitis National Quality Strategy Domain: Efficiency and Cost Reduction 2018 OPTIONS FOR INDIVIDUAL MEASURES: REGISTRY ONLY MEASURE TYPE: Process
More information9/30/2016. Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS
Dr. Janell Mayer, Pharm.D., CGP, BCPS Dr. Lindsey Votaw, Pharm.D., CGP, BCPS 1 2 Untoward Effects of Antibiotics Antibiotic resistance Adverse drug events (ADEs) Hypersensitivity/allergy Drug side effects
More informationAN ABSOLUTE SECRET. by Tigger Montague. Order the complete book from the publisher Booklocker.com
In the voice of her eldest male Australian Shepherd, author and canine nutrition expert Tigger Montague tackles the many aspects of whole-food canine diets, along with the wonderful and sometimes complex
More informationDisclosures. Principles of Antimicrobial Therapy. Obtaining an Accurate Diagnosis Obtain specimens PRIOR to initiating antimicrobials
Disclosures Principles of Antimicrobial Therapy None Lori A. Cox MSN, ACNP-BC, ACNPC, FCCM Penn State Hershey Medical Center Neuroscience Critical Care Unit Obtaining an Accurate Diagnosis Determine site
More informationEDUCATIONAL COMMENTARY A PRIMER IN ANTIBIOTICS FOR THE LABORATORY PROFESSIONAL
Linsey Donner, MPH, CPH, MLS (ASCP) CM Assistant Professor, Microbiology and Serology College of Allied Health Professions, Division of Medical Laboratory Science University of Nebraska Medical Center
More informationCountdown to the New Veterinary Feed Directive
Countdown to the New Veterinary Feed Directive Where we are going and what got us here Mike Apley Kansas State University 2003 - Daptomycin cyclic lipopeptides 2000 - Linezolid - oxazolidinones 1985 Imipenem
More informationThe Beagle Brain in Stereotaxic Coordinates
The Beagle Brain in Stereotaxic Coordinates Xavier Palazzi The Beagle Brain in Stereotaxic Coordinates Xavier Palazzi Sanofi-Aventis 3, Digue d Alfortville 94140 Alfortville France xavier.palazzi@sanofi-aventis.com
More informationAntibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut
Antibiotics: mode of action and mechanisms of resistance. Slides made by Special consultant Henrik Hasman Statens Serum Institut This presentation Definitions needed to discuss antimicrobial resistance
More informationFoundations in Microbiology Seventh Edition
Foundations in Microbiology Seventh Edition Talaro Chapter 12 Drugs, Microbes, Host The Elements of Chemotherapy Principles of Antimicrobial Therapy Administer a drug to an infected person that destroys
More informationJEFFERSON COLLEGE COURSE SYLLABUS INTRODUCTION TO VETERINARY TECHNOLOGY
JEFFERSON COLLEGE COURSE SYLLABUS VAT101 INTRODUCTION TO VETERINARY TECHNOLOGY 3 Credit Hours Prepared by: Dana Nevois, RVT Revised 06/08 John Keck, Dean of Career & Technical Education 1 VAT101 INTRODUCTION
More informationCaring for Your. Salamander. Tatiana Tomljanovic Weigl Publishers Inc.
Caring for Your Salamander Tatiana Tomljanovic Weigl Publishers Inc. Project Coordinator Heather C. Hudak Design Warren Clark Published by Weigl Publishers Inc. 350 5th Avenue, Suite 3304, PMB 6G New York,
More informationANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE
ANTIMICROBIAL USE AND ANTIMICROBIAL RESISTANCE September 18, 2014 This document was prepared by the National Farmed Animal Health and Welfare Council. The Council was formed in 2010 to advise governments
More informationSAMPLE. Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals
VET01 5th Edition Performance Standards for Antimicrobial Disk and Dilution Susceptibility Tests for Bacteria Isolated From Animals This standard covers the current recommended methods for disk diffusion
More informationECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials
ECDC-EFSA-EMA Joint Opinion on Outcome Indicators on Surveillance of Antimicrobial Resistance and Use of Antimicrobials P.-A. Belœil (EFSA) and D. Monnet (ECDC) One Health Network on Antimicrobial Resistance
More informationHow is Ireland performing on antibiotic prescribing?
European Antibiotic Awareness Campaign 2016 November Webinar Series on Antibiotic Prescribing How is Ireland performing on antibiotic prescribing? Dr Rob Cunney National Clinical Lead HCAI AMR Clinical
More informationSales survey of veterinary medicinal products containing antimicrobials in France in Annual report
Sales survey of veterinary medicinal products containing antimicrobials in France in 2016 Annual report October 2017 Scientific edition Sales survey of veterinary medicinal products containing antimicrobials
More informationAntibiotic Prophylaxis in Spinal Surgery Antibiotic Guidelines. Contents
Antibiotic Prophylaxis in Spinal Antibiotic Guidelines Classification: Clinical Guideline Lead Author: Antibiotic Steering Committee Additional author(s): Authors Division: DCSS & Tertiary Medicine Unique
More information2019 COLLECTION TYPE: MIPS CLINICAL QUALITY MEASURES (CQMS) MEASURE TYPE: Process High Priority
Quality ID #65 (NQF 0069): Appropriate Treatment for Children with Upper Respiratory Infection (URI) National Quality Strategy Domain: Efficiency and Cost Reduction Meaningful Measure Area: Appropriate
More informationObjective 1/20/2016. Expanding Antimicrobial Stewardship into the Outpatient Setting. Disclosure Statement of Financial Interest
Expanding Antimicrobial Stewardship into the Outpatient Setting Michael E. Klepser, Pharm.D., FCCP Professor Pharmacy Practice Ferris State University College of Pharmacy Disclosure Statement of Financial
More informationChapter 14. Antimicrobial Agents. Mosby items and derived items 2008, 2002 by Mosby, Inc., an affiliate of Elsevier Inc.
Chapter 14 Antimicrobial Agents Principles of Antimicrobial Therapy Identification of the pathogen Gram stain Acid-fast stain Enzyme-linked immunosorbent assay (ELISA) Principles of Antimicrobial Therapy
More informationB. PACKAGE LEAFLET 1
B. PACKAGE LEAFLET 1 PACKAGE LEAFLET NICILAN 400 mg/100 mg tablets for dogs 1. NAME AND ADDRESS OF THE MARKETING AUTHORISATION HOLDER AND OF THE MANUFACTURING AUTHORISATION HOLDER RESPONSIBLE FOR BATCH
More informationBIOLACTAM. Product Description. An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity
BIOLACTAM www.biolactam.eu An innovative in vitro diagnostic for the rapid quantitative determination of ß-lactamase activity 1.5-3h 20 Copyright 2014 VL-Diagnostics GmbH. All rights reserved. Product
More informationANTIMICROBIALS 1. Gentamicin 2. Intermediate spectrum (2nd generation) cephalosporins include all of the following except 3.
ANTIMICROBIALS 1. Gentamicin a. Can be mixed in the same administration set as penicillin b. Most streptococci are sensitive to gentamicin c. If organisms are resistant to gentamicin they will also be
More informationUnasyn alternative if penicillin allergic
Unasyn alternative if penicillin allergic The following guidelines have been developed to assist physicians with the appropriate selection of prophylactic and empiric antibiotic therapy for potential and.
More informationEffectiv. q3) Purpose of Policy. Pharmacy: Antimicrobial subcommp&tittee of
Name ofpolicynupolicy:mber: Department: Approving Officer: Responsible Agent: Scope: Protected Antimicrobials 3364-133-106 Pharmacy: Antimicrobial subcommp&tittee of Chief Executive Officer Director of
More information